Skip to content
Forensic Analysis · Durable-Goods Wholesale · as of Nov 8, 2026

Resideo Technologies, Inc. (REZI)

A forensic read on Resideo Technologies, Inc. built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.

C · Mixed — selective
Forensic grade
Grey Zone
Financial health
2.4
Distress distance
4
Forensic signals
-16.9%
ROE
10.5%
Revenue growth

This free snapshot doesn't read filing or proxy text, so the auditor-quality and governance checks that can lower a grade were not evaluated (auditor quality, say on pay, board independence, going concern). Those checks only ever lower a grade, so the full analysis can land below the grade above but never above it — treat it as the most favourable reading, not the settled one.

Resideo Technologies, Inc. earns a C (Mixed — selective) forensic quality grade, and its balance-sheet distress test reads 2.4, placing it in the Grey zone. 4 forensic signals were flagged in its latest SEC filings, led by shareholder returns — halted.

What the filings flag

stopped
FY2023→FY2025
Shareholder returns — halted. Capital returns have STOPPED — $41M of buybacks + dividends in FY2023, but ~$0 in FY2025. A halt usually means the company is conserving cash.
+16.6%
FY2024→FY2025
Accruals ratio (% of NOA). Net operating assets grew +16.6% relative to their own average in FY2025 — scaled by NOA itself, not by total assets, which is what the Forensic Screens card's own accrual row divides by. Accruals are building faster than is comfortable — part of profit is sitting in the balance sheet rather than turning to cash. The build is led by inventory up +9% against +9% in cost of sales. A cash-flow measure on the same base agrees: reported earnings ran ahead of operating cash by 12% of net operating assets, against an accruals ratio of 16.6%. The two are computed differently: the accruals ratio is the change in net operating assets over average net operating assets, while the cash-flow figure is net income less operating cash flow over that same average.Accruals ratio: the year-over-year change in net operating assets, relative to their own average.NOA (net operating assets): the money tied up in running the business, operating assets minus operating liabilities.
90d
FY2024→FY2025
Inventory days. Days inventory outstanding moved from 82 to 90 FY2024→FY2025 (against cost of goods sold; inventory +9% vs +9% in cost of sales). Inventory is building a little faster than sales — watch for markdowns.
8.2%
FY2025
Return on invested capital. Return on invested capital is 8.2% in the latest fiscal year, against 8.2% in FY2023, having run between 6.6% and 8.2% across FY2023–FY2025 with no direction held. After-tax operating profit was $367M in FY2023 and $480M in FY2025, with operating income at 8.8% of revenue in FY2023, 7.7% in FY2024 and 8.1% in FY2025. The capital base behind it grew +31% across FY2023–FY2025, from $4.5B to $5.9B, and the return held at 8.2% to one decimal doing it, so the dollars added over that window earned no more than the 8.2% the older base was already earning.

Key fundamentals

Latest Revenue$7.47B
Revenue Growth YoY+10.5%
Revenue CAGR (2yr)+9.4%
Net Margin-7.1%
Free Cash Flow-$1.25B
Return on Equity-16.9%
Debt / Equity1.09x

The forensic grade and screens above are free — no account needed. Want the AI investment read on top — the 0–100 rating, thesis, bull-vs-bear, red flags and the 12-month scenario, written from Resideo Technologies, Inc.'s actual 10-K/10-Q/8-K filings?

Generate the AI investment read →

No credit card · informational only, not investment advice · see the track record

← Browse all forensic stock analyses

Data from SEC EDGAR public filings · metrics as of Nov 8, 2026. Forensic signals flag probability, not certainty.

See a wrong number? Report an error with the filing it should match.